Stock ALMKT MAUNA KEA TECHNOLOGIES
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Mauna Kea Technologies

Equities

ALMKT

FR0010609263

Market Closed - Euronext Paris
Other stock markets
 16:27:41 03/05/2024 BST 		5-day change 1st Jan Change
0.4 EUR +0.38% Intraday chart for Mauna Kea Technologies +5.40% -15.07%
04-30 Mauna Kea Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-29 Mauna Kea Technologies SA Announces the Opening of A French Center of Excellence for the Use of Cellvizio in Lung Cancer Diagnostics CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mauna Kea Technologies: Publication of the 2023 Annual Financial Report
BU
Mauna Kea Technologies : Publication of the 2023 Annual Financial Report
PU
Mauna Kea Technologies Announces the Opening of a French Center of Excellence for the Use of Cellvizio® in Lung Cancer Diagnostics
BU
Mauna Kea Technologies : Inside Information / Information on annual revenues
PU
Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales
BU
Mauna Kea Technologies : Reports Full Year 2023 Results and Q1 2024 Sales
PU
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank
BU
Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults
BU
Mauna Kea Technologies : Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults
PU
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio
BU
Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults
BU
MAUNA KEA TECHNOLOGIES REPORTS FULL YEAR 2023 SALES OF EUR10.5M, UP +42% VS 2022
AQ
Mauna Kea Technologies : Inside Information / Other news releases
PU
Mauna Kea Technologies Announces the Publication of Positive Results of a Randomized Controlled Trial in the Field of Interstitial Lung Disease
AQ
Mauna Kea Technologies secures an equity line financing with Vester Finance limited to a maximum of 11.4% of the capital
AQ
Mauna Kea Technologies Announces Sales of EUR4.2 million for the first quarter of 2023, up 121% from 2022
AQ
Mauna Kea Technologies Announces the Publication of Results of the First in Human Clinical Study Combining Robotic-Assisted Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy for Lung Cancer
AQ
Mauna Kea Technologies reports its Financial Results for the First Half of 2022
AQ
Mauna Kea Technologies Announces Success of Clinical Trial on Prediction of Remission in Patients with Inflammatory Bowel Disease and its Publication in Gastroenterology
AQ
Mauna Kea Technologies : Announces 2022 Nine Month Sales Results
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALMKT Stock
  4. News Mauna Kea Technologies
  5. Press Releases